Q3 2025 Earnings Call Transcript January 14, 2026 Compass Diversified misses on earnings expectations. Reported EPS is ...
CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled data ...
Creative Bloq on MSN
The 6 best InDesign alternatives
Another strong InDesign alternative is VivaDesigner, which comes in both desktop and browser-based flavours and packs in ...
TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the "Company" or "TRX Gold") reported its results for the first quarter ...
Regions Financial Corp. today reported fourth quarter 2025 earnings of $514 million and diluted EPS of $0.58. For the full-year 2025, earnings were $2.1 billion and diluted EPS was $2.30. Adjusted ...
These overlooked Dividend Kings offer accelerating dividend growth, improving profitability, and long-term bullish momentum ...
The Trump Administration’s exhaustive examination of materials on the convicted sex trafficker Jeffrey Epstein is drawing ...
13h
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended December 2025 by going ...
Learn how degree of financial leverage (DFL) affects earnings per share (EPS) and how to calculate DFL for insightful ...
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback